Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 76420-494

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 76420-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zolpidem 01)

Chemical Structure (Zolpidem 01)
Chemical structure diagram of the active ingredient Zolpidem Tartrate. The image shows the molecular framework including aromatic rings and functional groups that comprise the compound.*
FDA Label Image

Figure 1 (Zolpidem 02)

Figure 1 (Zolpidem 02)
A pharmacokinetic curve comparing zolpidem plasma concentrations (ng/mL) over time (hours) for 12.5 mg zolpidem tartrate extended-release tablets versus 10 mg zolpidem tartrate immediate-release tablets. The graph shows plasma levels rising, peaking, and gradually declining for both formulations, with the extended-release maintaining higher concentrations for a longer duration.*
FDA Label Image

Principal Display Panel (6.25 mg Tablet Bottle Label)

Principal Display Panel (6.25 mg Tablet Bottle Label)
Packaging labels for Zolpidem Tartrate ER Tablets, USP 6.25 mg extended-release oral tablets by Enovachem Pharmaceuticals, showing package quantities of 30, 60, 90, and 100 tablets. Each label includes NDC, source, distributed by Centaur Pharmaceuticals Pvt. Ltd., description, batch, lot, and storage instructions at 20-25°C (68-77°F).*
FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle Label)

Principal Display Panel (12.5 mg Tablet Bottle Label)
Packaging labels for Zolpidem Tartrate ER Tablets, USP 12.5 mg, extended release oral tablets from Enovachem Pharmaceuticals. The labels include NDC codes 76420-496-30, 76420-496-60, 76420-496-90, and 76420-496-01 with quantities 30, 60, 90, and 100 tablets respectively. Labels mention distribution by Centaur Pharmaceuticals Pvt. Ltd. and storage/cautionary instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.